Therapeutic cancer targeting peptides
- PMID: 12385037
- DOI: 10.1002/bip.10257
Therapeutic cancer targeting peptides
Abstract
Antitumor monoclonal antibodies have shown clinical promise as cancer cell surface targeting agents. More tumor targeting antibodies are likely to be approved by the FDA in the next few years. However, there are two major limitations in antibody-targeted therapy: large size and nonspecific uptake of the antibody molecules by the liver and the reticuloendothelial system. These result in poor tumor penetration of antibody pharmaceuticals and dose-limiting toxicity to the liver and bone marrow. Peptides are excellent alternative targeting agents for human cancers, and they may alleviate some of the problems with antibody targeting. In the last decade, several investigators have successfully used combinatorial library methods to discover cell surface binding peptides that may be useful for cancer targeting. The phage-display library technique and the "one-bead one-compound" combinatorial library method are the two approaches that have been used. Cancer cell surface receptors or endothelial cell surface receptors of the neovasculature are the two popular therapeutic targets for cancer. Results from preclinical studies with some peptides are encouraging in their targeting potential.
Copyright 2002 Wiley Periodicals, Inc.
Similar articles
-
From combinatorial chemistry to cancer-targeting peptides.Mol Pharm. 2007 Sep-Oct;4(5):631-51. doi: 10.1021/mp700073y. Epub 2007 Sep 20. Mol Pharm. 2007. PMID: 17880166 Review.
-
Synthesis and screening of a random dimeric peptide library using the one-bead-one-dimer combinatorial approach.Bioconjug Chem. 2006 Mar-Apr;17(2):335-40. doi: 10.1021/bc0502659. Bioconjug Chem. 2006. PMID: 16536463
-
Cancer-specific ligands identified from screening of peptide-display libraries.Curr Pharm Des. 2004;10(19):2335-43. doi: 10.2174/1381612043383944. Curr Pharm Des. 2004. PMID: 15279612 Review.
-
Combinatorial discovery of tumor targeting peptides using phage display.J Cell Biochem. 2003 Oct 15;90(3):509-17. doi: 10.1002/jcb.10634. J Cell Biochem. 2003. PMID: 14523985
-
Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.Biopolymers. 2002;66(6):399-418. doi: 10.1002/bip.10356. Biopolymers. 2002. PMID: 12658727
Cited by
-
Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein-Protein Interaction.ACS Chem Biol. 2024 Feb 16;19(2):308-324. doi: 10.1021/acschembio.3c00521. Epub 2024 Jan 20. ACS Chem Biol. 2024. PMID: 38243811 Free PMC article.
-
Targeting Peptides: The New Generation of Targeted Drug Delivery Systems.Pharmaceutics. 2023 Jun 3;15(6):1648. doi: 10.3390/pharmaceutics15061648. Pharmaceutics. 2023. PMID: 37376097 Free PMC article. Review.
-
Photochemistry of phthalimidoadamantane dipeptides: effect of amino acid side chain on photocyclization.Photochem Photobiol Sci. 2023 Sep;22(9):2071-2080. doi: 10.1007/s43630-023-00430-4. Epub 2023 May 6. Photochem Photobiol Sci. 2023. PMID: 37148465
-
Fully synthetic macromolecular prodrug chemotherapeutics with EGFR targeting and controlled camptothecin release kinetics.Polym Chem. 2018 Nov 14;9(42):5224-5233. doi: 10.1039/c8py01047a. Epub 2018 Sep 25. Polym Chem. 2018. PMID: 36660314 Free PMC article.
-
Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells.Drug Des Devel Ther. 2022 Jun 27;16:1963-1974. doi: 10.2147/DDDT.S367586. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35783198 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources